The comparative efficacy of two solutions of bupivacaine, 0.5% plain (isobaric -specific gravity 1.010), and 0.4% bupivacaine (hyperbaric -specific gravity 1.(27) in 4% dextrose, for spinal anaesthesia was studied in 67 patients. Both solutions were clinically satisfactory (94% completely successful neural blockade). Hyperbaric bupivacaine blocks a greater number of spinal segments (p < 0.01), causes a more rapid fall in blood pressure (p < 0.05), and is more predictable in effect with regard to the number of segments blocked and to the lateralisation of the block. The duration of perioperative analgesia with the hyperbaric preparation is, however, shorter -3.8 hours as opposed to 5.8 hours (p < 0.01) -but this was likely to be due to the smaller total dosage of bupivacaine used in the hyperbaric group. It is concluded that either solution may be used satisfactorily in clinical practice. The isobaric solution, however, despite its ready availability, is less satisfactory than the hyperbaric because its effect with regard to the extent of blockade is less predictable.
solutions, compares their effects and emphasises practical aspects of their respective clinical uses.
MATERIALS AND METHODS
Sixty-seven consecutive patients, presenting mainly for orthopaedic and plastic surgery (Table 1 ), were studied. The anaesthetist obtained informed consent preoperatively from the patient or his agent, and prescribed pethidine and atropine premedication as appropriate. On the day of operation, patients who were not already receiving an intravenous infusion had a 160 cannula inserted under local anaesthesia, and 200 to 500 ml of dextran, molecular weight 70,000 (Macrodex 6%) in normal saline infused depending on the clinically estimated blood volume deficit.
When baseline pulse and blood pressure recordings had been taken, patients were placed TABLE 1 Surgical operations performed highest dermatome at which pinprick sensation was lost.
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Operation
The rapidity and degree of fall in systolic blood pressure measured with an Hip TOTAL   23  3  3  3  2  3  3  5  6   7 9 67 in a lateral flexed position. Intravenous fentanyl 25-75 JAg (six patients) and/or low-dose ketamine,12 20-40 mg (23 patients) was used as indicated to assist with the positioning of patients who had painful fractures. Using an aseptic technique and a midline approach at the L3-4 interspace, a 220, 3.5-inch needle was used to locate the subarachnoid space. The injection was then performed slowly and without barbotage, the actual dose of bupivacaine injected being determined by the clinical judgement of each of the four anaesthetists involved. The dosage range of bupivacaine in hyperbaric solution was 8-16 mg (2-4 ml) and 15-25 mg (3-5 ml) in the isobaric solution. The patients were then returned to the level supine position and breathed oxygenenriched air via a 28070 ventimask.
The following recordings were made: 1. The time of onset of analgesia as judged by the loss of pinprick sensation over the anterior thigh (L2-3) was tested at a maximum interval of one minute. 2. The onset of motor block at L2-3 as judged by the loss of normal power in the hip flexor muscles, i.e. onset of grade 4 power, * was tested at one-minute intervals. 
5.
oscillotonometer at five-minute intervals for 20 minutes after the injection and then quarter-hourly. If the clinical response of the patient demanded it, more frequent recordings were made but the five-minute readings were recorded for the purposes of statistical analysis. The duration of analgesia as judged by the patient's report of the onset of postoperative pain. Two solutions were studied. The isobaric solution studied was commercially available as "standard" Marcain® 0.5% plain. This solution is free of bactericide, antioxidant and preservative. The hyperbaric bupivacaine was prepared as suggested by Ooodison and Josyala,1O by mixing dextrose 20% 1.0 ml (additive-free) and Marcain® 0.5% plain 4.0 ml. This resulted in a 5 ml solution of bupivacaine 0.4% in dextrose 4%. As no solution of bupivacaine stronger than 0.50[0 was available, it was not possible to prepare a hyperbaric solution without reducing the concentration of the solution to less than 0.5%.
The pH and specific gravity (SO) of the hyperbaric solution were 5.58 and 1.027 (range 1.026-1.028) respectively, and of the "isobaric" solution, 5.73 and 1.010 respectively. The specific gravity and pH of both solutions were measured at 21°, the likely injectate temperature in clinical practice, using an Atago refractometer (model 52834) and Radiometer PHM62 pH meter. Cerebrospinal fluid (CSF) pH is normally 7.4-7.6 and specific gravity, normally, 1.003-1.009. 14 The SO of the hyperbaric solution fell within the 1.020-1.040 SO range of most hyperbaric spinal anaesthetic solutions. 15 Two randomly allocated groups of patients, one of which received hyperbaric and the other isobaric bupivacaine, were studied. To allow for the variability of administered bupivacaine dosage, some results are expressed on a per milligram basis. Normally distributed data are represented with mean and one standard deviation (SD) values, otherwise the median and range is quoted. Statistical comparisons are based on the Wilcoxon rank sum test. 
RESULTS
The groups were well matched for age, weight and sex (Table 2) , and were also comparable with regard to the types of operations performed. A larger proportion of patients in the isobaric group received low-dose ketamine before being positioned for spinal injection. Analysis of the data showed that there was no difference in the pattern of blood pressure response to the spinal blockade between the patients who received ketamine and those who did not. This was completely satisfactory in 63 patients (94070) . A resume of the four partially unsatisfactory blocks is provided in Table 3 . (Table 4) This was rapid (less than three minutes) with both solutions and there was no significant difference between them. The recorded time to the onset of surgery (Table 5 ) could not be relied on to reflect onset of surgical anaesthesia as factors other than the onset of blockade frequently delayed surgery, but in many instances surgery was commenced at three to five minutes after injection. (Table 4) The onset was rapid (less than four minutes) with no significant difference between the solutions.
Onset of analgesia

Onset of motor block
Number of segments blocked (Figure 1)
The hyperbaric solution blocked a significantly greater number of spinal segments per milligram of bupivacaine (p < 0.01). One mg of bupivacaine in hyperbaric solution blocked an average of 1.4 spinal segments, while 1.0 mg in isobaric solution blocked 0.9 segments.
The mean dose of bupivacaine was 12.3 mg (SD 2.2 mg) in the hyperbaric and 17.5 mg (SO 2 mg) in the isobaric group. The average extent of blockade in the two groups was similar, More rapid adoption of supine position after injection.
More rapid adoption of supine position after injection.
? increased dosage. Figure 1 represents the regression lines relating to the extent of blockade to the varying doses injected of the two solutions. (Table 4) The hyperbaric solution caused a greater fall in systolic pressure (p < 0.05), e.g. 15 mg of hyperbaric bupivacaine resulted in a mean 38070 fall in systolic pressure while the same dose of isobaric solution produced a mean 26% reduction. 6. Percentage fall in systolic pressure per spinal segment blocked (Table 4) There was no significant difference between the solutions, the mean fall being 1.7% of control systolic blood pressure per segment blocked with the hyperbaric solution and 1.8% with the isobaric solution. 7. Time to maximum fall in systolic pressure (Table 4) This was significantly (p < 0.05) less with the hyperbaric solution, the mean being 11.3 minutes as opposed to 16.9 minutes for the isobaric. (Table 6) The mean duration in the isobaric group, 5.8 hours, was significantly longer than in the hyperbaric group, 3.8 hours (p < 0.01). As stated (No_ 4 above), the' mean dose of bupivacaine was 12.3 mg in the hyperbaric group and 17.5 mg in the isobaric group. There was no difference between the two groups in the mean number of spinal segments blocked. 
Percentage fall in systolic pressure per mg of bupivacaine injected
Duration of analgesia
DISCUSSION
This study confirms that bupivacaine (in both hyper-and isobaric solutions) is a satisfactory long-acting local anaesthetic for subarachnoid use. It demonstrates that the extent of blockade and the rapidity and extent of the reduction in blood pressure is greater with hyperbaric bupivacaine. The hyperbaric solution had a shorter duration of action which in this study is likely to have been due to the smaller dose of bupivacaine used in this group.
There was a 940/0 incidence of completely satisfactory blockade and the four unsatisfactory results occurred during the early stages of the study. Greater experience with dosage and positioning largely obviated this early partial lack of success (Table 3) . Immediate resumption of the supine position seems to be important after an injection of the isobaric SG 1.010 solution as delay may result in a unilateral block, the lateralisation of which is unpredictable, sometimes blocking the upper and sometimes the lower side ( Table 3 ). The reason for this is unknown, but factors that might affect predictability of action are discussed below.
The onset of action of both preparations was rapid. The onset times of sensory and of motor blockade (Table 4 ) correspond with the findings of Roy, Multani and Lala, 3.05 and 5.05 minutes, respectively.7 However, further study documenting the onset of total motor blockade or of surgical analgesia might corroborate the clinical impression that a more rapid and reliable onset of dense sensory/motor block occurs with the hyperbaric solution.
The extent of neural blockade (Figure 1 ) was significantly greater per mean mg dose of bupivacaine in the hyperbaric than in the isobaric group (p < 0.01). The average block in Anaesthesia and Intensive Care, Vol, 12, No, 2, May, 1984 this study, 16 segments (T7 to S5), required a mean of 11.4 mg (2.84 ml) of hyperbaric bupivacaine compared with 17.4 mg (3.48 ml) of isobaric bupivacaine. This is consistent with the findings of Kitahara et al. 16 who demonstrated, using a radioactive tracer, that in supine patients a hyperbaric solution spreads from the injection site at the apex of the lumbar lordosis, along the sacral and thoracic curves, to a greater extent than an isobaric solution. A consistent trend in recent clinical studies,II,l7,18 using tetracaine, amethocaine and bupivacaine respectively, further confirms that, for a given milligram dose of local anaesthetic, hyperbaric solutions spread more extensively than isobaric solutions.
There was a 1.7-1.8% mean fall in resting systolic blood pressure per spinal segment blocked regardless of which solution had been used (Table 4 ). This suggests that the extent of blood pressure fall is related primarily to the number of spinal segments blocked, not to any baricity differences between the solutions.
The rate of fall in blood pressure is more rapid following injection of hyperbaric solution (Table 4 ). This is consistent with the findings of Gray et al. l7 who, using tetracaine, showed that a hyperbaric solution was more rapid in onset than an isobaric solution.
As regards postoperative analgesia, the known long action of bupivacaine in other applications also applies to its use in spinal analgesia ( This long action of spinal bupivacaine 0.5% is supported by two reports of total spinal anaesthesia following its accidental subarachnoid injection during attempted epidural injection, the effects of one lasting seven hours,19 and the other, in which adrenaline was used, nine hours. 2o Moore (1980) 10 has demonstrated that the addition of adrenaline to spinal bupivacaine results in a significant (48%) prolongation of its action. It should not be inferred, however, that surgical anaesthesia is of this duration. The median operation times in this study were 77.5 and 60 minutes for the hyperbaric and isobaric groups, (3.5 ml) tClinical impression of more rapid onset of profound or surgical blockade with hyperbaric solution. 'Probably related to greater dose of bupivacaine required to produce a given extent of blockade. respectively ( Table 5 ). Although most of these blocks would have been expected to last some time longer, it is noteworthy that one hyperbaric block lasted only 90 minutes, and another from the isobaric group waned at 120 minutes ( Table 3) .
The longer duration of action of the isobaric solution is most likely due to the greater mass of bupivacaine used in this group, 17.5 mg as opposed to 12.3 mg in the hyperbaric group (Table 6 ). Brown et al., 18 using amethocaine, have also shown that a greater mass dosage results in more prolonged blockade. However, there is also some evidence that reduced baricity per se may be associated with prolongation of neural blockade. 17 ,18,2l,22 An index of the predictability of the extent of blockade which may result from any given dose of bupivacaine was obtained by assessing the consistency (reproducibility) of the dose/effect relationships for the two solutions. The isobaric fared less well (less predictable) in that there was a greater scatter about the mean in the number of segments blocked in this group. This greater degree of scatter is reflected in the greater standard deviation of the extent of blockade (mean 16 segments, SO 3.5) in the isobaric than in the hyperbaric group (mean 16.8 segments, SO 2.9). The degree of scatter was further quantitated by calculating the coefficient of variation* which proved to be 'Coefficient of variation = Standard deviation (number of segments blocked) Mean (dose of bupivacaine injected) 28070 greater for the isobaric than for the hyperbaric.
This observation, together with the lack of predictability with regard to lateralisation of blockade (Table 3) , may correspond with the experience of Cameron et al. 2 who commented on "difficulty to control" as a feature of isobaric bupivacaine.
Perhaps an explanation is that the pattern of spinal spread would be expected to depend on the magnitude of the SO difference between the injected solution and the CSF into which it is deposited. The hyperbaric preparation (SO 1.027) would appear to be of sufficient density for it to be always heavier than CSF, regardless of variations in CSF SO (normal range 1.003-1.009). The isobaric solution (SO 1.010), however, would be more likely to behave unpredictably as a result of small variations in CSF SO, possibly even outside the normal range.
It is concluded that the wide availability of bupivacaine, its long duration of action, lack of neurotoxicity,23,24 and amide structure, which offers greater stability in solution over estertype local anaesthetics, makes it a useful addition to the small range of agents available for spinal blockade. 2s -27 Table 7 , in summarising the clinical features of the two solutions used in this study, shows that the hyperbaric preparation offers the important benefit of increased predictability of effect at the expense of a lesser duration of action and a more rapid fall in blood pressure.
Anaesthesia and Inrensive Care, Vol. 12 It may be that predictability of spread and duration of action could be optimised if more concentrated solutions of bupivacaine, e.g. 0.75_1.0070 4 . 8 ,22 were to become available. This would afford opportunities to systematically evaluate the effects of, for example, solutions of intermediate specific gravity on various injected dosages and possibly define an optimum specific gravity of solution and concentration of bupivacaine for clinical subarachnoid anaesthesia.
